Myriad Genetics, Inc. (MYGN)
NASDAQ: MYGN · Real-Time Price · USD
4.560
-0.010 (-0.22%)
Jun 8, 2026, 10:30 AM EDT - Market open
Myriad Genetics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 829 | 824.5 | 837.6 | 753.2 | 678.4 | 690.6 | |
Revenue Growth (YoY) | -0.28% | -1.56% | 11.21% | 11.03% | -1.77% | 23.96% |
Cost of Revenue | 249 | 247.9 | 252.2 | 236.2 | 202 | 197.6 |
Gross Profit | 580 | 576.6 | 585.4 | 517 | 476.4 | 493 |
Selling, General & Admin | 537.7 | 536.8 | 560 | 572.9 | 514.7 | 537.8 |
Research & Development | 106.4 | 106.8 | 113.4 | 88.7 | 85.4 | 81.9 |
Other Operating Expenses | 324.8 | 319.4 | 35.5 | 112.8 | 16.9 | 63.8 |
Total Operating Expenses | 968.9 | 963 | 708.9 | 774.4 | 617 | 683.5 |
Operating Income | -388.9 | -387.2 | -123.5 | -257.4 | -140.6 | -190.5 |
Interest Income | 2.2 | 1.8 | 1.7 | 2.5 | 2.6 | 0.7 |
Interest Expense | -13.8 | -10.5 | -7.8 | -2.9 | -3.2 | -6.6 |
Other Non-Operating Income (Expense) | 0.7 | 0.8 | 1.1 | -4.4 | 0.6 | 139.3 |
Total Non-Operating Income (Expense) | -10.9 | -7.9 | -5 | -4.8 | 0 | 133.4 |
Pretax Income | -399.8 | -395.1 | -123.5 | -262.2 | -140.6 | -57.1 |
Provision for Income Taxes | 0.1 | -29.2 | 3.8 | 1.1 | -28.6 | -29.9 |
Net Income | -399.9 | -365.9 | -127.3 | -263.3 | -112 | -27.2 |
Net Income to Common | -399.9 | -365.9 | -127.3 | -263.3 | -112 | -27.2 |
Shares Outstanding (Basic) | 93 | 93 | 91 | 83 | 81 | 78 |
Shares Outstanding (Diluted) | 93 | 93 | 91 | 83 | 81 | 78 |
Shares Change (YoY) | 2.36% | 2.21% | 9.42% | 2.73% | 3.33% | 4.28% |
EPS (Basic) | -4.30 | -3.95 | -1.41 | -3.18 | -1.39 | -0.35 |
EPS (Diluted) | -4.30 | -3.95 | -1.41 | -3.18 | -1.39 | -0.35 |
Shares Outstanding | 94.4 | 93.5 | 91.3 | 89.9 | 81.2 | 80 |
Free Cash Flow | -13.3 | -13.8 | -27.7 | -174.1 | -151.6 | 0.6 |
Free Cash Flow Per Share | -0.14 | -0.15 | -0.31 | -2.10 | -1.88 | 0.01 |
Gross Margin | 69.96% | 69.93% | 69.89% | 68.64% | 70.22% | 71.39% |
Operating Margin | -46.91% | -46.96% | -14.74% | -34.17% | -20.73% | -27.58% |
Profit Margin | -48.24% | -44.38% | -15.20% | -34.96% | -16.51% | -3.94% |
FCF Margin | -1.60% | -1.67% | -3.31% | -23.11% | -22.35% | 0.09% |
EBITDA | -337.1 | -333.5 | -62.3 | -195.5 | -87.9 | -127.7 |
EBITDA Margin | -40.66% | -40.45% | -7.44% | -25.96% | -12.96% | -18.49% |
EBIT | -388.9 | -387.2 | -123.5 | -257.4 | -140.6 | -190.5 |
EBIT Margin | -46.91% | -46.96% | -14.74% | -34.17% | -20.73% | -27.58% |
Effective Tax Rate | -0.03% | 7.39% | -3.08% | -0.42% | 20.34% | 52.36% |